ABSTRACT
Background/Objective: Coronavirus disease 2019 (COVID-19) is a viral respiratory illness that inflames the mucous membrane. Alveolar injury and eventually pneumonia result from this. It is brought on by the positive-sense single-stranded RNA virus SARS-CoV-2, also referred to as the novel coronavirus. The signs and symptoms of COVID-19 include fever, dry cough, exhaustion, sore throat, diarrhoea, headache, conjunctivitis, nasal congestion, body aches and pains, fatigue, loss of taste and smell, a skin rash, and discoloration of the fingers or toes. The main focus of research has been on current antiviral medications as prospective COVID-19 treatments. Hence, the present work was focused for clinical studies for the determinations of SARS-COV-2 (COVID-19) safety and efficacy of the new natural health drink of "Earth Tea". The product of "Earth Tea" Manufactured By Martin Sinclair B4B Corp,40, Remsen Ave, Brooklyn, NY 11212,United States. Method(s): An Open Label, Multicenter, Multi-Dose, Single Arm Treatment Clinical Trial in Human Adult Patients with Mild COVID-19 was the main goal of the study. To assess the safety and effectiveness of "Earth Tea" for COVID-19 as well as the safety and tolerability of a multi-dose given to human adult patients with COVID-19 infections. Result(s): In the analysis, patients showed a significant reduction in clinical cure and micro biologically cure analysis on Day 02 of evaluation visit. Moreover, significant reduction in the RT-PCR report noted on Day-02 and there were no adverse events reported during course of the study. Therefore, there were no Serious adverse events or deaths reported in this study. Conclusion(s): Based on these results obtained in the study, the product is an Earth Tea was found to have a significant efficacy and also a safe product. Copyright © 2022 Wolters Kluwer Medknow Publications. All rights reserved.